Results 171 to 180 of about 34,491 (205)

Proton pump inhibitors use and the risk of osteoporosis and fractures: A two-sample Mendelian randomization study. [PDF]

Medicine (Baltimore)
Li P, Wu R, Shi H.
europepmc   +1 more source

Evaluation of Human-Approved Active Pharmaceutical Ingredients Against Lactate Dehydrogenase from Theileria annulata. [PDF]

Acta Parasitol
Akar S, Orlenco M, Ugurel E, Danış Ö, Turgut-Balik D.   +4 more
europepmc   +1 more source

QSPR modelling of PPI drugs using hybrid topological indices. [PDF]

Front Chem
Monisha L, Jayagopal R.
europepmc   +1 more source

Combination of proton-pump inhibitor and anti-CD3 F(ab')₂ for islet neogenesis and immune modulation in type 1 diabetes. [PDF]

Immunother Adv
Wu TY, Chen CY, Chen M, Wang CH, Kao AP, Wang KH, Chuang KH, Lin SY.   +7 more
europepmc   +1 more source

Physiologically based pharmacokinetic modeling of fluconazole: interpretation of gender-dependent pharmacokinetics and cytochrome P450 inhibition. [PDF]

Front Pharmacol
Ishida K, Tanna RS, Yang J, Lai Y.
europepmc   +1 more source

Syringaldehyde inhibits NFκB-mediated inflammation and apoptosis and activates Nrf2/HO-1 signaling to reduce HCl/ethanol-induced gastric injury. [PDF]

Naunyn Schmiedebergs Arch Pharmacol
Yalinbas-Kaya B, Cesur S, Ince S.
europepmc   +1 more source

Phytochemical Profiling, Molecular Docking Study, and Gastroprotective Effect of Matricaria chamomilla L. Aqueous Extract in Ethanol-Induced Gastric Ulcer in Mice. [PDF]

Chem Biodivers
Bouhadjar M, Naimi D, Cheriet M, Barros L, Finimundy TC, Fadlaoui H, Djabali D.   +6 more
europepmc   +1 more source

Stability of proton pump inhibitors for use in hypersensitivity evaluation. [PDF]

J Allergy Clin Immunol Glob
Wanandy T, Handley SA, Patel RP, Anwar S, Le TA, Lau WY, Wiese MD.   +6 more
europepmc   +1 more source

Erratum: Comment on "Evaluation of the Long-Term Administration of Proton Pump Inhibitors (PPIs) in the Mineral Nutrient's Bioavailability". [PDF]

ACS Omega
Cavalcante LN, Souza MHLP.
europepmc   +1 more source

Reply: Including Vonoprazan With PPIs Challenges the Drug-Interaction Hypothesis. [PDF]

JACC Asia
Nishikura T, Yamamoto K, Watanabe H, Morimoto T, Kimura T.   +4 more
europepmc   +1 more source